» Articles » PMID: 39741187

Loss of YTHDC1 MA Reading Function Promotes Invasiveness in Urothelial Carcinoma of the Bladder

Overview
Journal Exp Mol Med
Date 2024 Dec 31
PMID 39741187
Authors
Affiliations
Soon will be listed here.
Abstract

Bladder cancer poses significant clinical challenges due to its high metastatic potential and poor prognosis, especially when it progresses to muscle-invasive stages. Here, we show that the mA reader YTHDC1 is downregulated in muscle-invasive bladder cancer and is negatively correlated with the expression of epithelial‒mesenchymal transition genes. The functional inhibition or depletion of YTHDC1 increased the migration and invasion of urothelial cells. Integrative analysis of multimodal sequencing datasets provided detailed insights into the molecular mechanisms mediating YTHDC1-dependent phenotypes and identified SMAD6 as a key transcript involved in the invasiveness of urothelial carcinoma of the bladder. Notably, SMAD6 mRNA colocalized less with YTHDC1 in tumoral tissues than in paratumoral tissues, indicating disrupted binding during cancer progression. Our findings establish YTHDC1-dependent mA reading as a critical epitranscriptomic mechanism regulating bladder cancer invasiveness and provide a paradigm for the epitranscriptomic deregulation of cancer-associated networks.

References
1.
Linder B, Grozhik A, Olarerin-George A, Meydan C, Mason C, Jaffrey S . Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. Nat Methods. 2015; 12(8):767-72. PMC: 4487409. DOI: 10.1038/nmeth.3453. View

2.
Liao Y, Smyth G, Shi W . featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2013; 30(7):923-30. DOI: 10.1093/bioinformatics/btt656. View

3.
Lee J, Wang R, Xiong F, Krakowiak J, Liao Z, Nguyen P . Enhancer RNA m6A methylation facilitates transcriptional condensate formation and gene activation. Mol Cell. 2021; 81(16):3368-3385.e9. PMC: 8383322. DOI: 10.1016/j.molcel.2021.07.024. View

4.
Brabletz S, Schuhwerk H, Brabletz T, Stemmler M . Dynamic EMT: a multi-tool for tumor progression. EMBO J. 2021; 40(18):e108647. PMC: 8441439. DOI: 10.15252/embj.2021108647. View

5.
Li W, Ye K, Li X, Liu X, Peng M, Chen F . YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway. J Exp Clin Cancer Res. 2022; 41(1):250. PMC: 9382764. DOI: 10.1186/s13046-022-02460-9. View